Table 2.
COVID-19 characteristics
| Median days from the onset of symptoms (n = 103) | 3 (2–6) |
|---|---|
| Initial COVID-19 classification (n = 114) | |
| Asymptomatic | 11 (9.7) |
| Mild | 60 (52.6) |
| Moderate | 11 (9.7) |
| Severe/critical | 32 (28) |
| Cause of hospital admission (n = 115) | |
| COVID-19 | 30 (26.1) |
| Non-COVID-19 causesa | 23 (20) |
| Not admitted | 62 (53.9) |
| Treatment of COVID-19 | |
| Remdesivir | 28 (24.4) |
| Inhaled steroids | 22 (19.1) |
| Convalescent plasma | 6 (5.2) |
| Systemic steroids | 35 (30.4) |
| Baricitinib | 6 (5.2) |
| Progression to severe COVID19 | 22 (19.1) |
| Invasive mechanical ventilation | 7 (6.1) |
| Death | 11 (9.7) |
| COVID-19-related death | 9 (7.8) |
a15 patients hospitalized for febrile neutropenia